Related Experiment Video
Updated: Sep 9, 2025

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
Decoding ATXN2 Phosphocode: Structural Insights and Therapeutic Opportunities in Disease
Apoorva Pai Kalasa Anil Kumar1, Suhail Subair1, Prathik Basthikoppa Shivamurthy1
1Yenepoya University, Mangalore, India.
Abstract:
Ataxin-2 (ATXN2), a key RNA-binding protein, regulates RNA metabolism, stress granule formation, and neuronal homeostasis, with dysregulated phosphorylation contributing to Spinocerebellar Ataxia type 2 (SCA2), amyotrophic lateral sclerosis (ALS), and cancer. This review integrates structural biology, phosphoproteomics, and interactome analyses to map six critical phosphosites (S772, T741, S624, S684, S784, S889) within ATXN2's intrinsically disordered regions. Modulated by kinases GSK3β and CDK13 and phosphatases like INPP5F, these sites orchestrate interactions with RNA-binding partners (e.g., ATXN2L, FXR2, STAU2) and co-regulated proteins (e.g., TP53BP1, NUP153), driving pathogenesis through disrupted autophagy, nucleocytoplasmic transport, and stress granule dynamics. We propose targeted therapies, including GSK3β inhibitors for ALS, antisense oligonucleotides for SCA2, and MTOR modulators for cancer, to restore ATXN2 function. By elucidating phosphocode of ATXN2, this work highlights novel avenues for precision medicine in neurodegenerative and oncogenic diseases.
Insights
This study maps critical phosphorylation sites on Ataxin-2 (ATXN2), revealing how their regulation impacts RNA metabolism and contributes to neurodegenerative diseases like Spinocerebellar Ataxia type 2 (SCA2) and amyotrophic lateral sclerosis (ALS), as well as cancer.
Area of Science:
- Molecular Biology
- Neuroscience
- Oncology
Background:
- Ataxin-2 (ATXN2) is a crucial RNA-binding protein involved in RNA metabolism, stress granule dynamics, and neuronal health.
- Dysregulated phosphorylation of ATXN2 is implicated in the pathogenesis of Spinocerebellar Ataxia type 2 (SCA2), amyotrophic lateral sclerosis (ALS), and various cancers.
Purpose of the Study:
- To comprehensively map and analyze critical phosphosites within ATXN2's intrinsically disordered regions.
- To elucidate the role of ATXN2 phosphorylation in regulating protein interactions and cellular processes relevant to disease.
- To identify potential therapeutic targets for ATXN2-related disorders.
Main Methods:
- Integration of structural biology, phosphoproteomics, and interactome analyses.
- Identification and characterization of six key ATXN2 phosphosites (S772, T741, S624, S684, S784, S889).
- Analysis of kinase (GSK3β, CDK13) and phosphatase (INPP5F) modulation of these phosphosites.
Main Results:
- Detailed mapping of six critical ATXN2 phosphosites within intrinsically disordered regions.
- Demonstration that these phosphosites modulate interactions with RNA-binding proteins and co-regulated proteins.
- Evidence linking altered ATXN2 phosphorylation to disrupted autophagy, nucleocytoplasmic transport, and stress granule dynamics.
Conclusions:
- Elucidation of the ATXN2 phosphocode provides a mechanistic understanding of its role in neurodegeneration and cancer.
- Targeted therapies, including kinase inhibitors and antisense oligonucleotides, show promise for treating ATXN2-related diseases.
- This research opens new avenues for precision medicine in treating complex diseases involving ATXN2 dysfunction.
Related Concept Videos
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Cell Specific Gene Expression
X-Inactivation
Translation
Translation Produces the Building Blocks of Life
Proteins are...
Leaky Scanning

